Description
Indication & Scope
Fultagliptin Benzoate Tablets improves glycemic control in adult patients with type 2 diabetes mellitus.
- Mechanism: Long-acting selective DPP-4 inhibitor, prolongs circulating GLP-1 and GIP activity to induce glucose-dependent insulin secretion and suppress glucagon secretion, lowering fasting and postprandial blood glucose.
- Drug class: DPP-4 inhibitor, oral once-weekly anti-diabetic agent.
- Clinical use: Monotherapy or combination therapy with metformin for long-term glycemic management in adults with type 2 diabetes.
| Generic Name | Fultagliptin Benzoate Tablets |
| Brand Name | XinLiTing |
| Ingredient | Fultagliptin Benzoate Tablets |
| Dosage Form | Tablets |
| Package | 6mg*14 tablets/box; 12mg*14 tablets/box |
| Conditions Treated | Type 2 diabetes mellitus in adult patients |
| Taboos | 1. Hypersensitivity to fultagliptin benzoate or tablet excipients
2. Personal history of DPP-4 inhibitor-induced acute pancreatitis 3. Severe end-stage renal failure |
| Place of origin | China |
| Prescription type | Prescription-only |
| Storage Conditions | Sealed, dry and light-proof storage below 30°C. |
| Manufacturer | XinLiTai Pharmaceutical Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H20240032; H20240033 |
| Approval Date | Jun 28, 2024 |
| Shelf Life | 36 months |
How to use ?
Recommended Dose: Fixed weekly dose: 50 mg orally once every 7 days.
Time: Same fixed day and time once weekly, taken with or without food.
Instructions for use:
1. No daily dosing required, strictly follow weekly administration schedule.
2. Counsel patients on symptoms of acute pancreatitis to seek immediate care.
3. Adjust dosage for moderate and severe renal impairment.
4. Tablets must be swallowed whole.
Interaction:
1. Sulfonylureas increase the risk of hypoglycemia.
2. No meaningful CYP450 drug-drug interactions with other diabetes medications.
3. ACE inhibitors slightly increase angioedema risk.
Side effects:
1. Common: Nasopharyngitis, headache, back pain, upper respiratory tract infection.
2. Severe: Acute pancreatitis, hypersensitivity angioedema, bullous skin reactions.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What is the unique feature of Fultagliptin Benzoate Tablets?
It is a long-acting DPP-4 inhibitor taken once weekly for type 2 diabetes.
What are common mild side effects of Fultagliptin Benzoate Tablets?
Nasopharyngitis, headache, back pain, and upper respiratory infection.
What serious adverse reaction may occur with Fultagliptin Benzoate Tablets?
Drug-induced acute pancreatitis and allergic angioedema.
When should dosage be adjusted when using Fultagliptin Benzoate Tablets?
Dose adjustment is required for moderate and severe renal impairment.
XinLiTing® | Fultagliptin Benzoate Tablets | Type 2 Diabetes | DengYueRX
INN: Fultagliptin Benzoate Tablets
Indications: Improve glycemic with type 2 diabetes
Dosage Form: Tablets
Strength: 6mg/tablet; 12mg/tablet
